JACOBS LEVY EQUITY MANAGEMENT, INC

Position in LUNG — Pulmonx Corp

CIK 884414 FLORHAM PARK, NJ

Position in LUNG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,574

-$30,260 QoQ

Shares Held

13,519

-63.5% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 107 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $576,060,759 across 26 Medical Devices names. LUNG ranks #25 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	2,772,232	$250,776,106
2	GEHC	GE HealthCare Technologies Inc.	1,862,023	$119,188,092
3	TXG	10x Genomics, Inc.	2,019,883	$77,442,314
4	TNDM	Tandem Diabetes Care Inc	2,006,429	$30,277,013
5	ATEC	Alphatec Holdings, Inc.	3,352,133	$28,995,950
6	AXGN	Axogen, Inc.	386,423	$17,848,878
7	NVCR	NovoCure Ltd	1,164,072	$17,635,690
8	VREX	Varex Imaging Corp	479,785	$5,004,157

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,574	13,519	-63.5%	Shares	Sole	2026-08-14
2026-03-31	$47,834	37,081	-78.8%	Shares	Sole	2026-05-15
2025-12-31	$386,250	174,774	-10.3%	Shares	Sole	2026-02-13
2025-09-30	$315,540	194,778	-25.2%	Shares	Sole	2025-11-17
2025-06-30	$674,482	260,418	+212.4%	Shares	Sole	2025-08-14
2024-12-31	$566,082	83,370	-72.3%	Shares	Sole	2025-02-14
2024-09-30	$2,498,282	301,361	-38.5%	Shares	Sole	2024-11-14
2024-06-30	$3,108,419	490,287	+148.5%	Shares	Sole	2024-08-14
2024-03-31	$1,829,304	197,336	-45.9%	Shares	Sole	2024-05-15
2023-12-31	$4,651,110	364,793	-27.8%	Shares	Sole	2024-02-14
2023-09-30	$5,220,565	505,379	-25.7%	Shares	Sole	2023-11-17
2023-06-30	$8,921,944	680,545	+4.3%	Shares	Sole	2023-08-14
2023-03-31	$7,296,168	652,609	+116.8%	Shares	Sole	2023-05-15
2022-12-31	$2,538,129	301,083	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.